Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- EXPAND Clinical Investigators
- , Guntis Karelis (Member of the Working Group)
- , Andrejs Millers (Member of the Working Group)
Research output: Contribution to journal › Article › peer-review
832
Citations
(Scopus)